Treating asthma in children with beclomethasone dipropionate: Pulvinal versus diskhaler

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 13, Issue 1, 2000, Pages 35-41

  De Benedictis, F M ^a   Boner, A ^b   Cavagni, G ^c   Caffarelli, C ^d   Ferraro, L ^a   Cantini, Luca ^e  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

^e CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Beclomethasone dipropronate; Diskhaler; DPIs; Pulvinal

Indexed keywords

BECLOMETASONE DIPROPIONATE;

ASTHMA; CHILD; CONFERENCE PAPER; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW;

EID: 0034102265     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2000.13.35     Document Type: Conference Paper

References (18)

1. Molina, M.J., and F.S. Rowland. 1974. Stratospheric sink for chlorofluoromethanes: Chlorine atom-catalysed destruction of ozone. Nature. 249:810-812.
2. Crompton, G.K. 1990. The adult patients difficulties with inhalers. Lung. 168(Suppl 1):658-662.
3. Berglund, E. 1990. Inhalation therapy: Problems and prospects. Eur. Respir. J. 3:830-832.
4. Clark, A.R., and A.M. Hollingworth. 1993. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing. J. Aerosol Med. 6:99-110.
5. Richards, R., and M. Saunders. 1993. Need for a comparative performance standard for dry powder inhalers. Thorax. 48:1186-1187.
6. Micheletto, C., R. Dal Negro, F. Ciani, A. Muzzi, and L. Cantini. 1995. Efficacy and tolerability of beclomethasone dipropionate (BDP) 200 μg dry powder delivered from two different inhalers in moderate asthma. Eur. Respir. J. 8(Suppl 19):427s.
7. Dal Negro, R., C. Micheletto, F. Ciani, A. Muzzi, E. Crimi, P. Filippa, G. Zappalà, L. Bertazzo, V. Squasi, and L. Cantini. 1997. Efficacy and safety of inhaled beclomethasone dipropionate dry powder in the treatment of chronic asthma: A controlled study vs. budesonide. Eur. Respir. J. 10(Suppl 25):351s.
8. Dal Col, G., L. Martinati, S. Mingoni, A. Boner, and L. Cantini. 1995. Salbutamol powder administered via a multi-dose and single-dose powder inhaler in the prevention of exercise-induced asthma in children. Pediatr. Asthma Allergy Immunol. 9:165-171.
9. Warner, J.O. 1995. Review of prescribed treatment for children with asthma in 1990. B.M.J. 311:663-666.
10. Quanjer, Ph.H., G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.-C. Yernault. 1993. Lung volumes and forced ventilatory flows. Eur. Respir. J. 6(Suppl 16):5-40.
11. Westlake, W.J. 1981. Bioequivalence testing-a need to rethink. Biometrics 37:591-593.
12. Pedersen, S. 1996. Inhalers and nebulizers, which to choose and why. Respir. Med. 90:69-77.
13. Dal Negro, R., C. Pomari, P. Turco, C. Micheletto, and L. Cantini. 1997. Peak inspiratory flow rate, as measured through a new powder inhaler, does not correlate with asthma severity or influence the effect of inhaled salbutamol. Adv. Ther. 14:181-191.
14. Engel, T., J.H. Heinig, F. Madsen, and K. Nikander. 1990. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur. Respir. J. 3:1037-1041.
15. Agertoft, L., and S. Pedersen. 1997. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J. Allergy Clin. Immunol. 99:773-780.
16. Pedersen, S., and O.R. Hansen. 1995. Budesonide treatment of moderate and severe asthma in children: A dose-response study. J. Allergy Clin. Immunol. 95: 29-33.
17. Jones, B., P. Jarwis, J.A. Lewis, and A.F. Ebbutt. 1996. Trials to assess equivalence: The importance of rigorous methods. B.M.J. 313:36-39.
18. Gibson, P.G., B.J. Wong, M.J. Hepperle, P.A. Kline, A. Girgis-Gabardo, and G. Guyatt. 1992. A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid. Clin. Exp. Allergy. 22:525-532.